| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 528,534 | 467,812 | 421,767 | 406,097 | | Cost of Revenue | 533,742 | 120,508 | 140,644 | (218,252) | | | Gross Profit | (5,208) | 347,304 | 281,123 | 624,349 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (220,057) | 193,448 | 170,149 | 519,553 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 64,516 | 63,814 | 58,214 | 53,271 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 150,333 | 90,042 | 52,760 | 51,525 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,851) | 4,133 | (2,096) | (4,994) | | Earnings Before Interest And Taxes | 150,998 | 94,175 | 50,664 | 46,531 | | Interest Expense | 41,599 | 40,093 | 35,077 | 33,530 | | Income Before Tax | 109,399 | 54,082 | 15,587 | 13,001 | | Income Tax Expense | 28,256 | 15,697 | 4,401 | (9,872) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 81,143 | 38,385 | 11,186 | 22,873 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 32,978 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 81,143 | 38,385 | 44,164 | 22,873 | | Preferred Stock And Other Adjustments | (242) | (243) | (242) | (243) | | | Net Income Applicable To Common Shares | $80,901 | $38,142 | $43,922 | $22,630 |
|
0.51% Nasdaq 
Income Statement
